MedTrace Logo

Sudden Cardiac Death in Systemic Right Ventricle

NCT03833843 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1240

Last updated 2021-05-18

No results posted yet for this study

Summary

In complete transposition of the great arteries (TGA) with previous atrial switch repair, and congenitally corrected transposition of the great arteries (ccTGA), the morphological right ventricle and its tricuspid valve continue to support the systemic circulation. This results in late complications including including sudden death.

This retrospective multicentric study aims to evaluate the prevalence of SCD in a contemporary population of patients with a systemic RV and identify specific risk factors for SCD and hemodynamically significant ventricular arrhythmia This registry records demographics, clinical, imaging data, electrophysiological and laboratory of patients with a sRV and a transposition of the great arteries Primary end points are defined by sudden cardiac death, near-miss sudden death, as well as sustained VT requiring defibrillation.

Conditions

Interventions

DIAGNOSTIC_TEST

imaging

ECG, Echocardiography and cardiac magnetic resonance imaging

Sponsors & Collaborators

  • KU Leuven

    collaborator OTHER

  • Erasmus Medical Center

    collaborator OTHER

  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER

  • Centre Hospitalier Universitaire Vaudois

    collaborator OTHER

  • University Hospital, Geneva

    collaborator OTHER

  • Hospitales Universitarios Virgen del Rocío

    collaborator OTHER

  • European Georges Pompidou Hospital

    lead OTHER

Principal Investigators

  • Magalie Ladouceur, Dr · Hopital Europeen Georges Pompidou

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-09-01
Completion
2019-09-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03833843 on ClinicalTrials.gov